2 Jia H J, Li Y, Zhao T S, et al. Antitumor effects of STAT3-shRNA and endostatin combined therapies, delivered by attenuated Salmonella, on orthotopically implanted hepatocarci-noma. Cancer Immunol Immunother, 2012, 61: 1977-1987
[3]
3 Farazi P A, DePinho R A. Hepatocellular carcinoma pathogenesis: From genes to environment. Nat Rev Cancer, 2006, 6: 674-687
[4]
7 Shangguan D H, Li Y, Tang Z W, et al. Aptamers evolved from live cells as effective molecular probes for cancer study. Proc Natl Acad Sci USA, 2006, 103: 11838-11843
[5]
8 Tang Z W, Shangguan D H, Wang K M, et al. Selection of aptamers for molecular recognition and characterization of cancer cells. Anal Chem, 2007, 79: 4900-4907
[6]
9 Sefah K, Tang Z W, Shangguan D H, et al. Molecular recognition of acute myeloid leukemia using aptamers. Leukemia, 2009, 23: 235-244
[7]
10 Chen H W, Medley C D, Sefah K, et al. Molecular recognition of small-cell lung cancer cells using aptamers. Chem Med Chem, 2008, 3: 991-1001
[8]
12 Kunii T, Ogura S, Mie M, et al. Selection of DNA aptamers recognizing small cell lung cancer using living cell-SELEX. Analyst, 2011, 136: 1310-1312
[9]
4 Fang X H, Tan W H. Aptamers generated from Cell-SELEX for molecular medicine: A chemical biology approach. Acc Chem Res, 2010, 43: 48-57
[10]
5 Jayasena S D. Aptamers: An emerging class of molecules that rival antibodies in diagnostics. Clin Chem, 1999, 45: 1628-1650
[11]
6 Cerchia L, Hamm J, Libri D, et al. Nucleic acid aptamers in cancer medicine. FEBS Lett, 2002, 528: 12-16
[12]
11 Zhao Z L, Xu L, Shi X L, et al. Recognition of subtype non-small cell lung cancer by DNA aptamers selected from living cells. Analyst, 2009, 134: 1808-1814
[13]
13 Sefah K, Meng L, Lopez C D, et al. DNA aptamers as molecular probes for colorectal cancer study. PLoS One, 2010, 12: e14269
[14]
14 Simaeys D V, Lopez C D, Sefah K, et al. Study of the molecular recognition of aptamers selected through ovarian cancer cell-SELEX. PLoS One, 2010, 11: e13770
[15]
15 Shangguan D H, Meng L, Charles C Z, et al. Identification of liver cancer-specific aptamers using whole live cells. Anal Chem, 2008, 80: 721-728
